Sorrento Therapeutics, Inc. SRNE
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.009 Day range 0.01
0.0001 52-week range 0.015
- YTD
- -88.46%
- 1 year
- -96.15%
- Market cap
- 165.38K
- EPS (ttm)
- -0.67
- Forward P/E
- -0.45
- YTD return
- -88.46%
- 1-year return
- -96.15%
- Volume
- 501.68K
- Avg volume
- 83.51K
- Open
- 0.009
- Previous close
- 0.0003
- Day's range
- 0.009 – 0.01
- 52-week range
- 0.0001 – 0.015
- Analysts
- Buy
- Price target
- 13.00 (+4333233.3%)
- Earnings date
- Oct 4, 2024
2Y -0.0037 (-92.50%)
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 0.817524
- 200-day average
- 1.58
Analyst view
Consensus: buy
Buy
Price target (mean) 13.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Oct 4, 2024
Expected Oct 4, 2024. Consensus EPS estimate -0.19.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 4, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Feb 28, 2023 | Dec 1, 2022 | -0.19 | — | — | — |
| Nov 8, 2022 | Sep 1, 2022 | -0.25 | -0.20 | +0.05 | +20.00% |
| Aug 15, 2022 | Jun 1, 2022 | -0.23 | -0.31 | -0.08 | -34.78% |
| May 5, 2022 | Mar 1, 2022 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2022 | Cantor Fitzgerald | init | — | Overweight |
| Mar 25, 2022 | HC Wainwright & Co. | main | — | Buy |
| Aug 9, 2021 | HC Wainwright & Co. | main | — | Buy |
| Jan 21, 2021 | Alliance Global Partners | init | — | Buy |
| Jul 31, 2020 | HC Wainwright & Co. | main | — | Buy |
| May 26, 2020 | Dawson James | init | — | Buy |
News
Sorrento Voyage Announces Expanded Luxury Boat Tours and Proposal Experiences Along the Amalfi Coast 
Sorrento Therapeutics (NASDAQ:SRNE) and Cortexyme (NASDAQ:CRTX) Head to Head Analysis 
Sorrento Therapeutics (NASDAQ:SRNE) versus NKGen Biotech (NYSE:NKGN) Head-To-Head Review 
Analyzing Sorrento Therapeutics (SRNEQ) and Its Competitors 
Financial Survey: Sorrento Therapeutics (SRNEQ) and Its Rivals 
DSI Introduces Westbury Sorrento Aluminum Railing with Bold Distinctive Mesh Stainless Steel Infills 
Sorrento Resources Announces Appointment of Alex Bugden as President and Chief Executive Officer 
Sorrento Resources to Sell Three Newfoundland Properties to Gold Hunter 
Sorrento Resources Announces Appointment of Alex Bugden as a Director and Qualified Person 
DSI Introduces Westbury(R) Sorrento Aluminum and Stainless Steel Mesh Railing
Your note
Sign in to keep a note on SRNE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ABG MANAGEMENT, LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 12, 2018 | 0 |
| ASGHAR NAJJAM | Chief Financial Officer | Stock Award(Grant) | Mar 15, 2021 | 56,974 |
| ASIA PACIFIC MEDTECH BVI, LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 23, 2018 | 8,617,510 |
| FOLLOWWILL DORMAN | Director | Sale | Dec 15, 2020 | 2,130 |
| JANDA KIM D | Director | Sale | Dec 26, 2021 | 3,000 |
| JI HENRY H | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 20, 2022 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| State Street Corporation | 10.73% | 50,637,571 | 15.56M | Dec 30, 2022 |
| Blackrock Inc. | 8.35% | 39,423,641 | 12.11M | Dec 30, 2022 |
| Vanguard Group, Inc. (The) | 6.26% | 29,535,954 | 9.08M | Dec 30, 2022 |
| Geode Capital Management, LLC | 1.89% | 8,905,936 | 2.74M | Dec 30, 2022 |
| B. Riley Financial, Inc. | 1.11% | 5,216,250 | 1.60M | Dec 30, 2022 |
| B. Riley Securities, Inc. | 1.11% | 5,216,250 | 1.60M | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 8.66% | 40,885,070 | 12.56M | Dec 30, 2022 |
| Vanguard Total Stock Market Index Fund | 2.72% | 12,843,725 | 3.95M | Sep 29, 2022 |
| iShares Russell 2000 ETF | 2.20% | 10,359,426 | 3.18M | Dec 30, 2022 |
| Vanguard Extended Market Index Fund | 1.17% | 5,513,243 | 1.69M | Sep 29, 2022 |
| Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 0.91% | 4,270,781 | 1.31M | Dec 30, 2022 |
| iShares Russell 2000 Value ETF | 0.87% | 4,113,608 | 1.26M | Dec 30, 2022 |